ArticleJournal of neuro-oncology2023

Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy.

Chongxian Hou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.